Your browser doesn't support javascript.
loading
A Promising New Anti-Cancer Strategy: Iron Chelators Targeting CSCs.
Chen, Yuehua; Ohara, Toshiaki; Xing, Boyi; Qi, Jiping; Noma, Kazuhiro; Matsukawa, Akihiro.
Afiliação
  • Chen Y; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Ohara T; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Xing B; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Qi J; Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Noma K; Department of Pathology and Experimental Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama 700-8558, Japan.
  • Matsukawa A; Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Acta Med Okayama ; 74(1): 1-6, 2020 Feb.
Article em En | MEDLINE | ID: mdl-32099242
ABSTRACT
Iron is a trace but vital element in the human body and is necessary for a multitude of crucial processes in life. However, iron overload is known to induce carcinogenesis via oxidative stress. Cancer cells require large amounts of iron for their rapid division and cell growth. Iron was recently found to play a role in cancer stem cells (CSCs); it maintains stemness during development. Iron also plays an important role in stemness by moderating reactive oxygen species. Thus, iron metabolism in CSCs is a promising therapeutic target. In this review, we summarize the roles of iron in cancer cells and CSCs. We also summarize anti-cancer therapeutic studies with iron chelators and describe our expectation of a new therapeutic strategy for CSCs on the basis of our findings.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quelantes de Ferro / Ferro / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Acta Med Okayama Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Quelantes de Ferro / Ferro / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Acta Med Okayama Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Japão